Mild cerebral thrombosis is very common in clinical practice, usually only symptoms such as dizziness, dullness, numbness and weakness of limbs, etc. If timely intervention is not given in the early stage, it may gradually progress leading to very serious symptoms of neurological deficits and leaving obvious sequelae. The treatment plan includes several aspects: First, intravenous infusion therapy, rtPA or urokinase intravenous thrombolytic therapy can be given within 6 hours of onset in the acute phase, and anti-platelet drugs, such as Ozagrel and tirofiban, and free radical scavenging drugs, such as edaravone and cytarabine, as well as other proprietary Chinese medicines, such as thromboxane and ginkgo biloba preparations, and drugs to promote Brain cell metabolism drugs, such as butylphthalein injection, etc. Oral drugs, mainly used for secondary prevention, such as anti-platelet drugs, aspirin, clopidogrel, etc.; statins, such as atorvastatin, resorvastatin, etc.; drugs to control blood pressure and blood sugar, such as nifedipine, metformin, etc. Third, surgical treatment, some patients combined with severe intracranial and extracranial vascular stenosis or occlusion, can be endovascular stent treatment and intracranial and extracranial artery bypass surgery, to maximize the prevention of cerebral thrombosis reoccurrence.